2-(Bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide

Catalog No. :
ACFIOM027
CAS No. :
40277-05-2
Molecular Formula :
C7H15Cl2N2O3P
Molecular Weight :
277.09

IUPAC Name:2-(bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide

2-(Bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide
IUPAC Name2-(bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide
MDL No.MFCD00869529
Molecular FormulaC7H15Cl2N2O3P
Molecular Weight277.09
SMILESOC1NP(OCC1)(N(CCCl)CCCl)=O
InChI KeyRANONBLIHMVXAJ-UHFFFAOYSA-N
Synonym4-hydroxycyclophosphamide;4-Hydroxycyclophosphonamide;Cyclophosphamide Impurity 2;2-(bis(2-chloroethyl)amino)-4-hydroxy-1,3,2-oxazaphosphinane 2-oxide;(R,S)-4-Hydroxy Cyclophosphamide [4-Hydroperoxy Cyclophosphamide (5mg) and Sodium Thiosulfate (5mg) in Water] DISCONTINUED PLEASE SEE H926301;Cyclophosphamide Impurity 11;2H-1,3,2-Oxazaphosphorin-4-ol, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide
CAS No.40277-05-2

Safety Data

Pictogram
ToxicHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H301-H340-H350-H360
Precautionary Statement(s)
P201-P202-P264-P270-P280-P301+P310+P330-P308+P313-P405-P501

Synthetic Route by SureRoute

1. ACFIOM027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYEFM715 route compound structure diagram
    ACYEFM7156055-19-2 In Stock
  2. Then
  3. ACFIOM027 route product structure diagram
    ACFIOM02740277-05-2
Inquiry

2. ACFIOM027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFIOM027 route product structure diagram
    ACFIOM02740277-05-2
Inquiry

Comments (0)